Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Hepatitis × Mycophenolic Acid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Myelodysplastic Syndromes 6 Lymphoma, Non-Hodgkin 6 Hodgkin Disease 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Leukemia, Myeloid, Acute 5 Leukemia 5 Multiple Myeloma 4 Lymphoma 4 Leukemia, Myeloid, Chronic-Phase 4 Leukemia, Myeloid, Accelerated Phase 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Neoplasms, Plasma Cell 3 Lymphoma, Mantle-Cell 3 Lymphoma, Large-Cell, Immunoblastic 3 Lymphoma, Large B-Cell, Diffuse 3 Lymphoma, Follicular 3 Congenital Abnormalities 3 Recurrence 2 Primary Myelofibrosis 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Neoplasms 2 Myasthenia Gravis 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, Large-Cell, Anaplastic 2 Lymphoma, B-Cell, Marginal Zone 2 Leukemia, Myelomonocytic, Chronic 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Immunoblastic Lymphadenopathy 2 Graft vs Host Disease 2 Dendritic Cell Sarcoma, Interdigitating 2

Interventions

Ursodeoxycholic Acid 1 Steroids 1 Prednisone 1 Mycophenolic Acid 1 Methylprednisolone Hemisuccinate 1 Methylprednisolone 1 Liquid Biopsy 1 Adrenal Cortex Hormones 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04810156 2022-12-14

I-HEP

Herlev Hospital

Phase 2 Unknown

Hepatitis, Neoplasms, Chemical and Drug Induced Liver Injury

Data powered by HemOnc (CC BY 4.0) Colophon ⚡